{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:55:13Z","timestamp":1791824113980,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T00:00:00Z","timestamp":1670716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GM1908"],"award-info":[{"award-number":["01GM1908"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.clineuro.2022.107559","type":"journal-article","created":{"date-parts":[[2022,12,11]],"date-time":"2022-12-11T09:36:23Z","timestamp":1670751383000},"page":"107559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Review and meta-analysis of neuropsychological findings in autoimmune limbic encephalitis with autoantibodies against LGI1, CASPR2, and GAD65 and their response to immunotherapy"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-8009","authenticated-orcid":false,"given":"Christoph","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Elben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David F.","family":"Tang-Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Holtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Perani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten J.","family":"Titulaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Johnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Illes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Borm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice G.","family":"Willison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stjepana","family":"Kovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"B\u00f6lte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2420-701X","authenticated-orcid":false,"given":"Nico","family":"Melzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2022.107559_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib2","doi-asserted-by":"crossref","first-page":"E529","DOI":"10.1503\/cmaj.181548","article-title":"Diagnosing autoimmune limbic encephalitis","volume":"191","author":"Budhram","year":"2019","journal-title":"Cmaj"},{"key":"10.1016\/j.clineuro.2022.107559_bib3","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00415-012-6657-5","article-title":"Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system","volume":"260","author":"Melzer","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/ene.13661","article-title":"Syndrome and outcome of antibody-negative limbic encephalitis","volume":"25","author":"Graus","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NRL.0b013e31813e34a5","article-title":"Limbic encephalitis and variants: classification, diagnosis and treatment","volume":"13","author":"T\u00fcz\u00fcn","year":"2007","journal-title":"Neurologist"},{"key":"10.1016\/j.clineuro.2022.107559_bib6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/ene.12186","article-title":"Neuropsychological course of voltage-gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis","volume":"20","author":"Frisch","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cortex.2018.01.003","article-title":"Accelerated long-term forgetting in focal epilepsies with special consideration given to patients with diagnosed and suspected limbic encephalitis","volume":"110","author":"Helmstaedter","year":"2019","journal-title":"Cortex"},{"key":"10.1016\/j.clineuro.2022.107559_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2018.05.020","article-title":"Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1\/CASPR2 antibodies","volume":"391","author":"Yeo","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2022.107559_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/practneurol-2020-002567","article-title":"Autoimmune encephalitis: clinical spectrum and management","volume":"21","author":"Uy","year":"2021","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-020-00989-x","article-title":"Cognitive impact of neuronal antibodies: encephalitis and beyond","volume":"10","author":"Gibson","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.clineuro.2022.107559_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","article-title":"LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes","volume":"89","author":"Binks","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2022.107559_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NRL.0000000000000087","article-title":"Autoimmune encephalitides: a broadening field of treatable conditions","volume":"22","author":"Kalman","year":"2017","journal-title":"Neurologist"},{"key":"10.1016\/j.clineuro.2022.107559_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1017\/cjn.2016.13","article-title":"Limbic encephalitis associated with GAD65 antibodies: brief review of the relevant literature","volume":"43","author":"Gagnon","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2022.107559_bib14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jocn.2007.12.003","article-title":"Limbic encephalitis \u2013 a review","volume":"15","author":"Anderson","year":"2008","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.clineuro.2022.107559_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.24189","article-title":"Seroprevalence of autoantibodies against brain antigens in health and disease","volume":"76","author":"Dahm","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri2529","article-title":"Losing your nerves? Maybe it\u00b4s the antibodies","volume":"9","author":"Diamond","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clineuro.2022.107559_bib17","doi-asserted-by":"crossref","unstructured":"R. Iorio, V.A. Lennoin, Neural antigen\u2010specific autoimmune disorders, 2012, pp. 104\u201321.","DOI":"10.1111\/j.1600-065X.2012.01144.x"},{"key":"10.1016\/j.clineuro.2022.107559_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107016","article-title":"CD19 + B-cells in autoantibody-negative limbic encephalitis","volume":"106","author":"Hansen","year":"2020","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.clineuro.2022.107559_bib19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/jnnp-2014-307875","article-title":"Automated volumetry of the mesiotemporal structures in antibody-associated limbic encephalitis","volume":"86","author":"Wagner","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2022.107559_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4103\/0972-2327.165454","article-title":"Autoimmune encephalitis: clinical diagnosis versus antibody confirmation","volume":"18","author":"Cyril","year":"2015","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2022.107559_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib24","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib26","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.clineuro.2022.107559_bib27","first-page":"1","article-title":"Neuropsychological performance in autoimmune limbic encephalitis: evidence from an immunotherapy-na\u00efve cohort","volume":"00","author":"Mueller","year":"2022","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.clineuro.2022.107559_bib28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.clineuro.2022.107559_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.clineuro.2022.107559_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/gps.4756","article-title":"A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores","volume":"33","author":"Carson","year":"2017","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.clineuro.2022.107559_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/WAD.0b013e3182420bfe","article-title":"Montreal cognitive assessment","volume":"27","author":"Freitas","year":"2013","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.clineuro.2022.107559_bib32","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0895-4356(94)90122-8","article-title":"The mini-mental state examination score and the clinical diagnosis of dementia","volume":"47","author":"Kukull","year":"1994","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.clineuro.2022.107559_bib33","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/jnnp-2015-310322","article-title":"A second chance-reoperation in patients with failed surgery for intractable epilepsy: long-term outcome, neuropsychology and complications","volume":"87","author":"Grote","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2022.107559_bib34","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/j.1528-1167.2012.03602.x","article-title":"Multifactorial etiology of interictal behavior in frontal and temporal lobe epilepsy","volume":"53","author":"Helmstaedter","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2022.107559_bib35","series-title":"Neuropsychological Assessment","author":"Lezak","year":"2012"},{"key":"10.1016\/j.clineuro.2022.107559_bib36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/10618600.1996.10474713","article-title":"A language for data analysis and graphics","volume":"4","author":"Ihaka","year":"1996","journal-title":"J. Comput. Graph. Stat."},{"key":"10.1016\/j.clineuro.2022.107559_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.clineuro.2022.107559_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000441944","article-title":"The treatment and follow-up of anti-LGI1 limbic encephalitis","volume":"75","author":"Yu","year":"2016","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2020.00304","article-title":"Functional and structural brain alterations in encephalitis with LGI1 antibodies","volume":"14","author":"Qiao","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.clineuro.2022.107559_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13760-015-0517-x","article-title":"Assessing the clinical features of LGI1 antibody encephalitis","volume":"116","author":"Zhao","year":"2016","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.clineuro.2022.107559_bib41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1080\/00207454.2019.1567507","article-title":"Clinical features of patients with anti-leucine-rich glioma inactivated-1 protein associated encephalitis: a Chinese case series","volume":"129","author":"Yang","year":"2019","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.clineuro.2022.107559_bib42","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/00207454.2018.1512985","article-title":"Three cases of antibody-LGI1 limbic encephalitis and review of literature","volume":"129","author":"Bing-Lei","year":"2019","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.clineuro.2022.107559_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/NDT.S292343","article-title":"Clinical features and long-term outcomes of anti-leucine-rich glioma-inactivated 1 encephalitis: a multi-center study","volume":"17","author":"Qiao","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.clineuro.2022.107559_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2020.585977","article-title":"Clinical features and gut microbial alterations in anti-leucine-rich glioma-inactivated 1 encephalitis\u2014a pilot study","volume":"11","author":"Ma","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2020.00852","article-title":"Clinical characteristics of cognitive impairment and 1-year outcome in patients with anti-LGI1 antibody encephalitis","volume":"11","author":"Hang","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/acn3.51297","article-title":"Flortaucipir (tau) PET in LGI1 antibody encephalitis","volume":"8","author":"Day","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bandc.2016.07.010","article-title":"Neuropsychological and FDG-PET profiles in VGKC autoimmune limbic encephalitis","volume":"108","author":"Dodich","year":"2016","journal-title":"Brain Cogn."},{"key":"10.1016\/j.clineuro.2022.107559_bib48","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/ene.14325","article-title":"Clinical characteristics and outcome of patients with autoimmune encephalitis: clues for paraneoplastic aetiology","volume":"27","author":"Iorio","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib49","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2014.05.048","article-title":"Natural course of LGI1 encephalitis: 3\u20135 years of follow-up without immunotherapy","volume":"343","author":"Szots","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2022.107559_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577268","article-title":"LGI1-antibody associated epilepsy successfully treated in the outpatient setting","volume":"345","author":"Uribe-San-Mart\u00edn","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clineuro.2022.107559_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-27914-z","article-title":"Amygdala enlargement and emotional responses in (autoimmune) temporal lobe epilepsy","volume":"8","author":"Holtmann","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clineuro.2022.107559_bib52","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.comppsych.2017.11.002","article-title":"LGI1 antibody encephalitis \u2013 detailed clinical, laboratory and radiological description of 13 cases in China","volume":"81","author":"Wang","year":"2018","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.clineuro.2022.107559_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis \u2013 clinical syndrome and long-term follow-up","volume":"87","author":"Van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2022.107559_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2020.00678","article-title":"The road to recovery: a pilot study of driving behaviors following antibody-mediated encephalitis","volume":"11","author":"Day","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-018-1099-z","article-title":"Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study","volume":"18","author":"Li","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib56","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1017\/cjn.2018.33","article-title":"Long-term cognitive outcomes in patients with autoimmune encephalitis","volume":"45","author":"H\u00e9bert","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2022.107559_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","volume":"74","author":"Finke","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2014.03.012","article-title":"Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis","volume":"271","author":"Brown","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clineuro.2022.107559_bib59","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s10072-019-03883-7","article-title":"Clinical characteristics and factors associated with short-term prognosis in adult patients with autoimmune encephalitis of non-neoplastic etiology","volume":"40","author":"Dong","year":"2019","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.clineuro.2022.107559_bib60","first-page":"3","article-title":"Immunoadsorption therapy in autoimmune encephalitides","author":"Onugoren","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.clineuro.2022.107559_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2020.102289","article-title":"Fixel-based analysis links white matter characteristics, serostatus and clinical features in limbic encephalitis","volume":"27","author":"Bauer","year":"2020","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.clineuro.2022.107559_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106082","article-title":"Clinical characteristics and outcomes of autoimmune encephalitis patients associated with anti-glutamate decarboxylase antibody 65","volume":"196","author":"Zhang","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.clineuro.2022.107559_bib63","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/ane.13281","article-title":"Clinical characteristics of GAD 65-associated autoimmune encephalitis","volume":"142","author":"Zhu","year":"2020","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.clineuro.2022.107559_bib64","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1007\/s00415-020-09807-2","article-title":"Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies","volume":"267","author":"Joubert","year":"2020","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib65","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yebeh.2016.10.016","article-title":"Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis","volume":"65","author":"Hansen","year":"2016","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.clineuro.2022.107559_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12868-020-00561-9","article-title":"Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?","volume":"21","author":"Li","year":"2020","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.clineuro.2022.107559_bib67","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.13297","article-title":"Distinct white matter integrity in glutamic acid decarboxylase and voltage-gated potassium channel-complex antibody-associated limbic encephalitis","volume":"57","author":"Wagner","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.clineuro.2022.107559_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.108378","article-title":"Executive deficits in neuropsychological testing differentiate between autoimmune temporal lobe epilepsy caused by limbic encephalitis and temporal lobe epilepsies with non-autoimmune etiologies","volume":"124","author":"Conradi","year":"2021","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.clineuro.2022.107559_bib69","first-page":"1","article-title":"Determinants of cognition in autoimmune limbic encephalitis\u2014a retrospective cohort study","author":"Mueller","year":"2021","journal-title":"Hippocampus"},{"key":"10.1016\/j.clineuro.2022.107559_bib70","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/0972-2327.132615","article-title":"Limbic encephalitis: clinical spectrum and long-term outcome from a developing country perspective","volume":"17","author":"Jagtap","year":"2014","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib71","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0404.2009.01204.x","article-title":"Autoimmune limbic encephalitis","volume":"120","author":"Vedeler","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.clineuro.2022.107559_bib72","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neubiorev.2020.08.015","article-title":"Psychiatric symptoms in anti glutamic acid decarboxylase associated limbic encephalitis in adults: a systematic review","volume":"119","author":"Vrillon","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.clineuro.2022.107559_bib73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamaneurol.2016.4538","article-title":"Rethinking outcomes in leucine-rich, glioma-inactivated 1 protein encephalitis \u201cgood\u201d isn\u2019t good enough","volume":"74","author":"Day","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clineuro.2022.107559_bib74","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.clineuro.2022.107559_bib75","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp-2020-325302","article-title":"Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management","volume":"92","author":"Abboud","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722004401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722004401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:43:01Z","timestamp":1759588981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846722004401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":75,"alternative-id":["S0303846722004401"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107559","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review and meta-analysis of neuropsychological findings in autoimmune limbic encephalitis with autoantibodies against LGI1, CASPR2, and GAD65 and their response to immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107559"}}